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Abstract
Objectives—To characterize the impact of uterine leiomyomas (fibroids) in a racially diverse
sample of women in the United States.
Study Design—A total of 968 women (573 White, 268 African-American, 127 other races)
aged 29–59 with self-reported symptomatic uterine leiomyomas participated in a national survey.
We assessed diagnosis, information seeking, attitudes about fertility, impact on work, and
treatment preferences. Frequencies and percentages were summarized. Chi-square test was used to
compare age groups.
Results—Women waited an average of 3.6 years before seeking treatment for leiomyomas, and
41% saw two or more healthcare providers for diagnosis. Almost a third of employed respondents
(28%) reported missing work due to leiomyoma symptoms, and 24% felt that their symptoms
prevented them from reaching their career potential. Women expressed desire for treatments that
do not involve invasive surgery (79%), preserve the uterus (51%), and preserve fertility (43% of
women under 40).
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Conclusions—Uterine leiomyomas cause significant morbidity. When considering treatment,
women are most concerned about surgical options, especially women under 40 who want to
preserve fertility.
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Introduction
Uterine leiomyomas (fibroids) are benign tumors of the uterus that affect approximately
80% of women.1, 2 Most leiomyomas are asymptomatic, and most women do not undergo
treatment. However, 25% of those affected have symptoms that impact activities of daily
living or are severe enough to require treatment. Leiomyoma symptoms include heavy or
prolonged menstrual bleeding, menstrual pain or cramping, passing blood clots, bloating,
bowel or bladder dysfunction, and fatigue.2 Uterine leiomyomas are the leading cause of
hysterectomy (also the most common treatment for this condition).3, 4 Uterine leiomyomas
have a three-fold increased relative risk and prevalence among African-American women.5
Few studies have attempted to gauge symptomatology of women with leiomyomas, assess
the way that women obtain information about the disease, or reveal how women use this
information to make treatment choices. A recently conducted international survey confined
its assessment to only bleeding and pain symptomology.6 In addition to the physical
symptoms, validated quality of life measures indicate that uterine leiomyomas impact
women emotionally, including increased fears about their health along with additional
considerations with regard to relationships, sexual function, body image, loss of control, and
hopelessness.7 Further, the economic impact of this disease is probably underestimated
given the limited amount of information on its impact on women’s work. The purpose of
this study is to provide a comprehensive assessment of the burden and impact of uterine
leiomyomas in a diverse group of women. Because of the potentially higher impact of
uterine leiomyomas on women of childbearing age, we attempted to quantitate the frequency
and magnitude of morbidity in women under the age of 40 compared to older age groups:
40–49 and 50–59.
Materials and Methods
We conducted a cross-sectional survey of United States (U.S.) women aged 29–59 from
December 1, 2011 to January 16, 2012. Our target sample was 1,000 participants. The
sampling frame for the survey was Harris Poll Online (HPOL), which is an actively
managed, continually monitored respondent panel owned by Harris Interactive (New York,
NY). The Focused Ultrasound Foundation was not included or named in any part of the
survey. No ads or links to the Foundation were included in the survey. The goal of HPOL is
to provide a representative sample of the general population while identifying and reaching
under-represented populations of interest. Harris Interactive uses a weighting algorithm with
propensity score adjustment to minimize the nonrandom selection bias inherent in internet-
based surveys.8, 9 In the present study, national representativeness of the final survey sample
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was sought to be achieved by a weighting algorithm based on age, education, region and
income information based on March 2010 Current Population Survey Database. HPOL
respondents are recruited from co-registration offers on partners’ websites, targeted emails
sent by online partners to their audiences, graphical and text banner placement on partners’
websites (including social media, news, search, and community portals), trade show
presentations, targeted postal mail invitations, and telephone recruitment of targeted
populations. Each recruitment source is carefully vetted through a rigorous interviewing and
testing process and then monitored for response quality on an ongoing basis. HPOL
respondent information is actively screened and updated along numerous demographic and
psychographic variables to allow for precision in the online sample. The email’s subject line
was “We need your opinion, please participate today!” The text said “Hello, The latest
Harris Poll Online survey is now open and we want your opinion! In order to receive the
reward mentioned, you will need to qualify and complete the survey. Panel participants
receive points and chances in a sweepstakes for cash prizes for all survey participation.
Neither the authors nor the Focused Ultrasound Foundation are involved in the HPOL
reward program. Additional details about Harris’ online panel are available online at (http://
www.harrisinteractive.com/MethodsTools/DataCollection/HarrisPollOnlinePanel.aspx and
http://www.harrisinteractive.com/vault/HI_SP_Sheet_SamplingSupportandDesign.pdf). The
Institutional Review Board (IRB) at Mayo Clinic judged the study to be exempt.
Respondents in the targeted sample pool received an email invitation describing the study in
general terms. The email directed those interested to a survey website. The survey was
conducted online using secure servers at Harris Interactive. Women were screened and
considered eligible to participate if they spoke English, had been diagnosed with
symptomatic uterine leiomyomas, had not had a hysterectomy, and were not pregnant.
To identify women with symptomatic uterine fibroids, we first asked participants if they had
experienced any of the following symptoms in the past 2 years and to select all that apply:
abdominal bloating and pressure/protruding abdomen/looking pregnant; passing blood clots
during your menstrual period; heavy or prolonged menstrual bleeding (i.e., menstrual flow
that soaks through sanitary pads or tampons every hour or consistently lasts longer than 7
days); abdominal pain/cramping/tightness; anemia; backache or leg pains; constipation;
bladder symptoms (difficulty urinating, frequent urge to urinate, etc.); fatigue; menstrual
pain/cramps; painful intercourse or lack of interest in sex. If a participant checked at least
one of the symptoms listed above, the next question stated, “You mentioned that you
experienced [insert response] in the past 2 years. Have you ever been diagnosed by a
healthcare professional with any of the following? Please select all that apply.
Endometriosis; Asymptomatic uterine fibroids (i.e., fibroids that are not causing you
symptoms or discomfort of any kind); Symptomatic uterine fibroids (i.e., fibroids that are
causing you symptoms or discomfort of any kind); None of the above.
The initial group of respondents included 370 women over the age of 50 (38% of the total
968 eligible respondents). Therefore, the initial age range of 21–50 was adjusted to 29–59
when no women under the age of 29 successfully screened into the study. Although the
older women who screened in are nearing menopause (and probable relief from symptoms
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of leiomyoma), they provided a valuable source for comparison of quality of life issues with
women under the age of 40.
Survey Instrument
The survey consisted of twelve screening questions, eight demographic questions, and
twenty-four questions concerning diagnosis and symptoms, coping with symptoms,
information seeking, fertility, and concerns about treatment. The average time to complete
the survey was 20 minutes.
Most survey questions were based on a 4- or 5-point Likert scale. For ease of presentation,
responses were combined into a smaller number of categories. For example, symptom
results reported as severe are a combination of the “severe” and “very severe” Likert points.
Those reported as concerns include points marked “all of the time” and “most of the time;”
those reported as important include the “important” and “very important” points grouped
together, and “not applicable” was a choice when a statement did not apply to that
respondent’s experience or when the respondent neither agreed nor disagreed with a
statement.
We also elicited responses on potential employment- and treatment-related concerns to
which respondents could choose one of the following options: concerned, very concerned,
somewhat concerned, unconcerned, very unconcerned, somewhat unconcerned, and not
sure. For ease of interpretation, the first three of the choices were combined to form a
“Concerned” category while the next three categories were combined to form a “Not
Concerned” category.
With formal permission from the Society for Interventional Radiology Foundation (Fairfax,
Virginia), we used quality of life questions from the Uterine Fibroid Symptom and Quality
of Life (UFS-QOL) questionnaire, which was designed and validated as a reliable tool to
measure health-related quality of life for women with leiomyomas.7
Statistical Analysis
Statistical analyses comprised of both bivariate and multivariate analyses. Bivariate analyses
were performed using Chi-squared test of goodness of fit for categorical covariates, and t-
test for continuous covariates.
Estimated prevalence ratios (PRs) were adjusted for potential confounding due to
differences in the baseline characteristics of the sampled subjects.10 Although log-binomial
models are suggested for estimating PRs, they are often difficult to fit due to well-known
problems of convergence of the resulting likelihood function; therefore, we used Zou’s
modified Poisson regression to estimate PRs with the youngest group of patients (age 29–
39) as the referent group.11, 12
A p-value of < 0.05 was considered statistically significant. Analyses were conducted using
Stata® statistical software, version 11.2 (StataCorp LP, College Station, Texas), which
provides capabilities for analyzing survey data.
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Response Rate and Participant Characteristics
Of the 140,231 people invited to participate in the online survey, 73,103 never clicked on
the link, 34,902 suspended the survey, and 31,258 did not qualify (23,850 did not have
symptomatic uterine fibroids, 5,010 were excluded because the target number of respondents
in their specific racial/ethnic category had been met, 1,927 had undergone hysterectomy,
187 were out of the desired age range, 161 were not female, 106 were pregnant,
breastfeeding, or did not meet menstrual cycle criteria, and 17 were not U.S. women)--
leaving the 968 (3%) who met each of the entry criteria, had symptomatic uterine fibroids
and were able to complete the survey. Table 1 exhibits the characteristics of the survey
respondents, sub-grouped by three age categories (29–39, 40–49, and 50–59). Sixty-four
percent of participants were White, 28% were Black (Black/African/African-American/
Afro-Caribbean), and 8% were from other racial backgrounds or of mixed racial
background. Most women were parous (69%). The percent of respondents within each age
category were 25%, 46%, and 29%, respectively. The majority of respondents (61%) were
married or in a civil union. Educational backgrounds included 72% who had completed
some form of higher education. Over half (66%) of the respondents were employed full time
(including self-employment). Of those employed who responded, 39% earned in excess of
$75,000 annually, and 23% reported an annual income of under $35,000 (Table 1).
The respondents in this survey reported having had uterine leiomyomas for a mean of 8.7
years (median 6 years) since diagnosis. Many women (42%) saw two or more healthcare
providers before being diagnosed; overall, women saw an average of 1.7 providers before
diagnosis. The mean amount of time to seek treatment for all women in the survey was 3.6
years, while the median wait time for seeking treatment was 2 years (Table 1). While 25%
of women sought treatment within the first year of experiencing symptoms, 32% waited
more than 5 years before seeking treatment for these symptoms. 87% reported discussing
one or more treatment options with their providers (Table 1).
Severity of Symptoms
We collected data on severity of symptoms experienced in the past 3 months and reported in
Table 2. Half of the women (50%) reported that they did not consider their menstrual cycle
to be “normal,” with 56% reporting that they had spotting or staining before or after their
cycle. Nearly a third of women (29%) characterized their cycles as heavy or with prolonged
bleeding and had severe menstrual pain or severe cramps. Note that when potential
confounding due to differences in patient characteristics was accounted for, most of the
menstrual and nonmenstrual symptoms reported in Table 2 were not statistically different
between the three age groups except for bladder symptoms, menstrual pain/cramps, and
painful intercourse. In general, women in the intermediate age group 40–49 had lower
prevalence ratios of those symptoms than those in the 29–39 age group.
Perceptions of Leiomyomas and Impact on Quality of Life and Employment
As shown in Appendix Table 1, women with leiomyomas had a number of concerns related
to their uterine leiomyoma diagnosis. Most reported fears, including being afraid that their
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leiomyomas will grow (79%), that there is something inside of them that doesn’t belong
there (69%), that they would experience future health complications (63%), that they will
need a hysterectomy (55%), that the leiomyomas would turn into cancer (54%),or that the
leiomyomas would affect their sex life (52%). However, when adjusted for their baseline
characteristics, the prevalence ratios in women in the three age groups did not differ by
different concerns..
Women under 40 (29–39) were also more concerned than their older counterparts (40–49
and 50–59) about soiling clothes or bedding (44% vs. 35% and 22%, respectively, P<0.001),
the negative impact on their femininity or sexuality (39%, vs. 17% and 11%, respectively,
P=0.01), and feeling sad, discouraged, or hopeless (36% vs. 17% and 7%, respectively,
P<0.001). Furthermore, approximately a third of the women under 40 (31%) reported that
their uterine leiomyomas made them feel “not in control of life,” as compared to 20% and
11% of the women 40–49 and 50–59, respectively (P=0.008) (Table 3).
Some of these differences persisted even after accounting for potential confounding due to
differences of baseline characteristics (Table 3). Specifically, as seen from the adjusted
prevalence ratios, younger women (29–39) were more likely to report “feel tired or worn out
a little/some of the time” or “feel self-conscious about weight gain a little/some of the time”
or “UF interfered with physical activities all/most of the time” or “UF interfered with daily
and social activities all/most of the time”.
Our survey also found significant age differences in the way that uterine leiomyomas affect
the lifestyle of respondents. Although every age group was affected, the women under 40
were more likely than women 40–49 and 50–59 to report that that their uterine leiomyomas
affected their relationship with their partner (33% vs. 19% & 10% P<0.001), affected their
ability to take care of their home/children (22% vs. 12% & 9%, P=0.01), and affected their
relationships with family/friends (21% vs. 13% & 9%, P<0.001) (Table 3). However, when
adjusted for the baseline characteristics, these differences were no longer statistically
significant.
Respondents perceived that uterine leiomyomas negatively impacted their career potential
and workplace environment (Appendix Table 2). We found significant differences in
perceptions of the impact on career advancement for women under age 40 compared with
women 40–49 and 50–59. When asked about their work-related experiences in the 3 months
prior to the study, 28% of employed respondents reported that their uterine leiomyomas
caused them to miss days of work, with a disproportionate impact on the women under 40
compared to older respondents (37% among women 40 and under vs. 30% and 16% among
women 40–49 and 50–59 respectively, P=0.002); further, 26% were prevented from carrying
out their normal work-related responsibilities (35% vs. 27% and 13%, P<0.001) and 24%
were prevented from reaching their true career potential (32% vs. 24% & 15%, P=0.03).
However, following multivariate adjustment, these differences were no longer statistically
significant.
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Women’s Preferences for Treatment
Uterine-sparing treatment options were important to women whether or not they were
considering a pregnancy (Table 4). The majority (51%) of survey respondents felt it was
important to have a leiomyoma treatment option that allowed a woman to keep her uterus,
and these percentages were significantly higher in women under 40 (65% vs. 47% each in
the older categories, P=0.021). Three-quarters of all participants (79%) and 84% of those
under 40 indicated that it was important to have a leiomyoma treatment option that did not
involve invasive surgery. One-fifth (20%) of all of the women surveyed thought it was
important to have treatment options that preserved the ability to achieve pregnancy, but a
higher percentage (43%) of women under 40 said that it was important to have leiomyoma
treatment procedures that protected the ability to have children. Sixty-five percent of women
under age 40 reported that uterine preservation was important compared to 47% of women
40–49 and 50–59. However, note that when baseline characteristics of the sampled women
were adjusted, these differences by age groups could not be sustained.
Comment
To our knowledge, this is the first large-scale survey of U.S. women with symptomatic
uterine leiomyomas to describe perceptions of the impact of the leiomyomas on quality of
life (symptoms, work, relationships, family, and sexual functioning) and concerns and
preferences for treatments. This comprehensive assessment of the impact of uterine
leiomyomas reveals the perspective of women from childbearing age to menopause. The
study findings are particularly relevant when viewed within the framework of the burden of
this condition. Uterine leiomyomas affect millions of women worldwide, and the cumulative
incidence in the U.S. is 70% to 80% by age 50.13 The professional and economic impact of
leiomyomas is likely underestimated. When including the costs of obstetrical outcomes
related to leiomyomas, the total cost of this disease increases from $5.9 billion to $34.4
billion annually in the U.S.14
Our findings provide useful, early information on the distribution of symptoms across age
categories for women with uterine fibroids. After adjustment for baseline characteristics,
most symptoms (Table 2) were found to be similar across the age groups. These findings
emphasize the effect of leiomyomas on physical functioning in women across the lifespan,
and also suggest the need for further investigation of how perceptions of symptoms impact
treatment seeking behaviors. Bladder symptoms, menstrual pain/cramps, and painful
intercourse were less often reported in women in the intermediate age range (40–49)
compared to the youngest age group (29–39). Differences in symptoms may be due, in part,
to variations in hormonal levels, perceptions of pain and discomfort or the initial size and
growth of uterine fibroids.15 The majority of women in our survey (66%) were concerned
about missed days from work. Prior data on loss of work productivity in women with
leiomyomas have been limited; no prior studies have documented the level of perceived
work impairment for women that are reported in this survey.16, 17 Further research that
incorporates women’s perception of work productivity can inform the development of
patient-centered outcomes for planning and implementing clinical trials that compare
treatment options. Additionally, fatigue played a substantial role in women’s perceptions of
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their health related quality of life. Further studies to develop patient-centered outcome
measures for symptoms of fatigue and work productivity are necessary to fully compare the
effectiveness of medical or surgical treatment options for leiomyomas.
Most women preferred non-invasive options for treatment irrespective of the desire for
childbearing. A considerable number of hysterectomies occur each year in the U.S., with
substantial costs for the healthcare system.17–20 Despite the curative effect of hysterectomy
for leiomyomas, the long-lasting health impact of hysterectomy of, even with ovarian
conservation, is not completely understood. Prior studies suggest that removal of the uterus
could result in fluctuations in hormonal mediators and iron balances that are thought to
contribute to CHD, cognition, and dementia.21, 22. The relative impact of patient preference
and patient-provider communication about the choice of hysterectomy remains unclear. Of
particular relevance is the role of shared decision-making in moving forward with
hysterectomy or other non-surgical treatments.
The findings from the current study suggest that women across age categories are seeking
information on alternatives to hysterectomy for a variety of reasons. Women verbalized the
need for information on treatment options that are noninvasive and that enable them to have
children in the future. Aside from fertility, many women expressed a clear desire to keep
their uterus. This may be due to a variety of factors, including the need to avoid lost time at
work for postoperative recuperation so that they can continue to support themselves and
their families or concerns regarding post-hysterectomy sexual function and femininity.
Women are well informed about drug therapies and hysterectomy.
This study has several limitations. The survey relied on self-report of leiomyomas, so some
misdiagnosis likely occurred. While validation of self-report has not been carried out in each
of the populations we surveyed, previous data for White and African-American women in
the U.S. show that over 90% of women who self-report uterine leiomyomas are confirmed to
have these lesions following review of the medical records.5, 23, 24 The lack of medical
record confirmation also means that the size, location, and number of leiomyomas cannot be
correlated with symptoms, work productivity or preferences for care. Since the study was
based on an online survey, the standard limitations of this method apply. 25, 26 In particular,
these results need to be interpreted in the backdrop of potential selection bias because only
women with internet access could respond to the survey. Economically and educationally
advantaged women are more likely to have responded to the survey. Another potential
limitation is recall bias. The age range of participants in the study varied widely. Some
women may not have accurately reported their age at diagnosis or the time period between
the beginning of their symptoms and seeking treatment. Finally, while we know the number
of women who had discussed surgical interventions with their physicians, we do not have
information on which surgical treatments they may have actually received, and therefore, the
impact of surgical interventions on their responses to treatment preferences.
These limitations notwithstanding, our study has important clinical and policy implications.
The results of this survey document the substantial effects of leiomyomas on women’s job
performance, quality of life, and concerns about intimate relationships across the lifespan.
Our study results also document the increased severity of symptoms and impairment in
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women under age 40, especially the perceived impact on fertility and healthy childbearing.
Women’s voices should be heard by payers and clinicians when considering the types of
treatment options that should be discussed, made available to, and reimbursed by payers.
The primary implication of our study is that the effect of uterine fibroids on women’s quality
of life deserves further attention. From a clinical perspective, our findings can inform the
conduct of qualitative research and provide an opportunity to systematically analyze
women’s views and preferences for care. Such formative work can be used to develop
clinical decision-making tools and to promote shared medical decision making for treatment
between women and their providers.27 Trials should be of sufficient size to provide direct
evidence on the effect of non-surgical and surgical treatments on patient-centered outcomes
(e.g., quality of life, physical functioning) and for analyses specific to women of
childbearing age. Finally, there is a critical need for studies of the direct and indirect (work
productivity, loss of work time) costs of leiomyomas to better inform clinicians and third
party payers.
Background and Objective
The relative risk for and prevalence of uterine leiomyoma, the leading cause of
hysterectomy, are 3-fold greater among African-American women. The purpose of this
study was to provide a comprehensive assessment of the burden and impact of uterine
leiomyomas in a diverse group of women. Because of the potentially higher impact on
women of childbearing age, we assessed the frequency and magnitude of morbidity in
women under age 40 vs 40–49 and 50–59 years.
Materials and Methods
We conducted a cross-sectional survey of US women aged 29–59 from Dec. 1, 2011,
through Jan. 16, 2012. Our target sample was 1000 participants.
We sought to achieve national representative within the final survey sample by applying a
weighting algorithm based on age, education, region, and income using information from the
March 2010 Current Population Survey Database.
Results
Of the 140,231 women invited to participate in the online survey, 968 (3%) met entry
criteria, had symptomatic uterine fibroids, and were able to complete the survey.
Respondents reported having had uterine leiomyomas for a mean of 8.7 years (median, 6
years) since diagnosis. Many (42%) had seen ≥2 health care providers (average, 1.7) before
diagnosis. The mean time to seek treatment was 3.6 years (median, 2 years) (Table). One
fourth (25%) had sought treatment within the first year of experiencing symptoms and 32%
had waited >5 years. Treatment options had been discussed with providers by 87%.
Most of the reported menstrual and nonmenstrual symptoms did not differ statistically
among age groups. The prevalence ratios were lower among women aged 40–49 years than
29–39 years.
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Women under 40 were more concerned than their older counterparts about soiling clothes or
bedding, the negative impact on their femininity or sexuality, and feeling sad, discouraged,
or hopeless. Among women under 40, 31% said uterine leiomyomas made them feel “not in
control of life” vs 20% and 11% of those aged 40–49 and 50–59, respectively (P=.008).
Uterus-sparing treatment options were important to women whether or not they were
considering pregnancy. A small majority (51%) of survey respondents, especially those
under 40, desired a treatment option that allowed the uterus to be retained. Most participants
(79%) and 84% of those under 40 considered it important to have a leiomyoma treatment
option that did not involve invasive surgery.
Comment
To our knowledge, this is the first large-scale survey of US women with symptomatic
uterine leiomyomas to describe their perceptions of the impact on quality of life and
concerns and preferences for treatment. Our findings are particularly relevant when viewed
within the framework of the burden of this condition. Uterine leiomyomas affect millions of
women worldwide; the cumulative US incidence is 70–80% by age 50. Including related
obstetrical outcomes increases the total US cost from $5.9 billion to $34.4 billion annually.
Our findings provide early information on the distribution of symptoms across age
categories for women with uterine fibroids. After adjustment for baseline characteristics,
most symptoms were similar across age groups. These findings emphasize the effect of
leiomyomas on physical functioning across the lifespan and suggest the need for further
investigation of ways in which perception of symptoms affects treatment-seeking behavior.
Bladder symptoms, menstrual pain/cramps, and painful intercourse were less often reported
in women in the intermediate age range (40–49) than the youngest (29–39). Differences in
symptoms may be due in part to variations in hormonal levels, perceptions of pain and
discomfort, or initial fibroid size and growth.
The majority of women (66%) were concerned about missed workdays. Prior data on loss of
work productivity in women with leiomyomas have been limited; no prior studies have
documented the levels of perceived work impairment for women that are reported in this
survey. Further research that incorporates women’s perception of work productivity could
inform the development of patient-centered outcomes for planning and implementing
clinical trials that compare treatment options.
Fatigue played a substantial role in women’s perceptions of their health-related quality of
life. Further studies to develop patient-centered outcome measures for symptoms of fatigue
and work productivity are necessary to compare the effectiveness of medical or surgical
treatment options for leiomyomas.
Most women preferred noninvasive options for treatment regardless of the desire for
childbearing. Our findings suggest that women across age categories are seeking
information on alternatives to hysterectomy for a variety of reasons. Women verbalized the
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need for information on treatment options that are noninvasive and preserve fertility. Many
women expressed a clear desire to keep their uterus aside from future childbearing.
The primary implication of our study is that the effect of uterine fibroids on quality of life
deserves further attention. Clinically, our findings can inform the conduct of qualitative
research and provide an opportunity to systematically analyze women’s views and
preferences for care. Such formative work can be used to develop clinical decision-making
tools and to promote shared decision making about treatment between women and their
providers.
Trials should be large enough to provide direct evidence on the effects of nonsurgical and
surgical treatments on patient-centered outcomes, such as quality of life and physical
functioning, and to permit analyses specific to women of childbearing age. Finally, there is a
critical need for studies of the direct and indirect (work productivity, loss of work time)
costs of leiomyomas to better inform clinicians and third-party payers.
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I'm afraid that the fibroids
will grow
<0.001
  Strongly/Somewhat agree 763 (79) 217 (87) 376 (85) 170 (62) 1.05 0.422 0.92 0.463
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  Strongly/Somewhat disagree 115 (12) 21 (9) 35 (8) 59 (21) ref ref
  Not applicable 90 (9) 10 (4) 33 (7) 46 (17) - -
I'm afraid there is something
inside me that doesn’t belong
there
<0.001
  Strongly/Somewhat agree 671 (69) 201 (81) 320 (72) 150 (54) 0.89 0.271 0.71 0.072
  Strongly/Somewhat disagree 208 (22) 38 (15) 90 (20) 80 (29) ref ref
  Not applicable 89 (9) 9 (4) 34 (8) 45 (16) - -




  Strongly/Somewhat agree 610 (63) 184 (74) 288 (65) 139 (51) 0.91 0.461 0.77 0.223
  Strongly/Somewhat disagree 251 (26) 53 (21) 111 (25) 87 (32) ref ref
  Not applicable 106 (11) 13 (5) 45 (10) 49 (18) - -




  Strongly/Somewhat agree 535 (55) 161 (65) 263 (59) 111 (40) 0.99 0.938 0.75 0.252
  Strongly/Somewhat disagree 317 (33) 73 (29) 129 (29) 114 (42) ref ref
  Not applicable 116 (12) 14 (6) 51 (12) 50 (18) - -




  Strongly/Somewhat agree 519 (54) 165 (66) 245 (55) 109 (40) 0.87 0.403 0.73 0.257
  Strongly/Somewhat disagree 352 (36) 71 (28) 157 (35) 125 (45) ref ref
  Not applicable 97 (10) 13 (5) 43 (10) 41 (15) - -




  Strongly/Somewhat agree 502 (52) 163 (65) 245 (55) 94 (34) 1.28 0.110 1.22 0.465
  Strongly/Somewhat disagree 304 (31) 67 (27) 127 (29) 110 (40) ref ref
  Not applicable 162 (17) 19 (8) 72 (16) 72 (26) - -





  Strongly/Somewhat agree 391 (40) 122 (49) 199 (45) 70 (26) 1.16 0.463 0.73 0.374
  Strongly/Somewhat disagree 375 (39) 102 (41) 150 (34) 123 (45) ref ref
  Not applicable 202 (12) 26 (10) 95 (21) 82 (30) - -




  Strongly/Somewhat agree 449 (46) 150 (60) 215 (49) 84 (30) 0.96 0.848 0.75 0.372
  Strongly/Somewhat disagree 415 (43) 87 (35) 190 (43) 138 (50) ref ref
  Not applicable 104 (11) 11 (5) 39 (9) 54 (19) - -
I'm afraid fibroids will affect
my
<0.001
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ability to have a successful
and
healthy pregnancy
  Strongly/Somewhat agree 242 (25) 123 (49) 97 (22) 21 (8) 0.94 0.745 0.44 0.053
  Strongly/Somewhat disagree 253 (26) 58 (23) 111 (25) 83 (30) ref ref
  Not applicable 474 (49) 68 (27) 235 (53) 171 (62) - -




  Strongly/Somewhat agree 364 (38) 131 (53) 170 (38) 63 (23) 0.89 0.586 0.55 0.123
  Strongly/Somewhat disagree 466 (48) 100 (40) 211 (48) 155 (56) ref ref
  Not applicable 138 (14) 18 (7) 63 (14) 57 (21) - -
Note: Data are weighted. Columns do not always sum to the total due to rounding.




































  Strongly/Somewhat agree 164 (26) 64 (35) 77 (27) 23 (13) 0.97 0.845 1.05 0.833
  Strongly/Somewhat disagree 474 (74) 120 (65) 205 (73) 150 (87) ref ref
Prevented me from reaching
my




  Strongly/Somewhat agree 152 (24) 59 (32) 68 (24) 25 (15) 0.93 0.598 0.90 0.607
  Strongly/Somewhat disagree 486 (76) 124 (68) 214 (76) 147 (85) ref ref
Caused me to miss days of
work
0.002
  Strongly/Somewhat agree 179 (28) 67 (37) 84 (30) 28 (16) 0.97 0.798 1.01 0.970
  Strongly/Somewhat disagree 458 (72) 116 (63) 198 (70) 144 (84) ref ref
Made me afraid I'll lose my
job
<0.001
  Strongly/Somewhat agree 75 (12) 39 (21) 28 (10) 9 (5) 1.15 0.098 1.22 0.127
  Strongly/Somewhat disagree 563 (88) 144 (79) 254 (90) 164 (95) ref ref
Prevented me from traveling
for
<0.001
  Strongly/Somewhat agree 93 (15) 36 (19) 44 (15) 14 (8) 1.01 0.909 1.11 0.497
  Strongly/Somewhat disagree 545 (85) 148 (81) 238 (85) 159 (92) ref ref
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  Concerned 421 (66) 121 (66) 195 (69) 105 (61) 1.06 0.722 0.92 0.736
  Not concerned 195 (31) 60 (33) 74 (26) 61 (35) ref ref
  Not sure 22 (3) 2 (1) 13 (5) 7 (4) - -
Potential loss of income 0.73
  Concerned 336 (53) 106 (58) 147 (52) 82 (48) 0.97 0.867 1.06 0.874
  Not concerned 272 (43) 69 (38) 122 (43) 80 (47) ref ref
  Not sure 30 (5) 7 (4) 13 (5) 10 (6) - -
Note: Data are weighted. Columns do not always sum to the total due to rounding.
P-values are from X2 statistics comparing responses from women age 29–39, 40–49 and 40–59. P-values < 0.05 are
considered statistically significant.
Appendix Table 3
Text from the Email that was sent to potential survey respondents from Harris Poll Online: Subject: We need your
opinion, please participate today!
[Start Survey] button
Hello, The latest Harris Poll Online survey is now open and we want your opinion! In order to receive the reward
mentioned you will need to qualify and complete the survey. To participate, please click the “Start Survey” button
above. If the button fails to launch the survey, please copy and paste the link below into the address bar of your browser.
For survey comments and concerns, contact the Survey Help Desk. You received this email because you are a member
of the Harris Poll Online Panel. The Harris Poll Online Panel is a product of Harris Interactive, 60 Corporate Woods,
Rochester, NY 14623-1457.”
On the side of the Email: it noted that qualifying and completing the survey would reward the participant with up to 100
HI points and an entry into a $10,000 sweepstakes. The length was 18 minutes, and a survey code. The bottom of the
Email included a link to unsubscribe from the Harris Poll Online.
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• The findings of this study can inform qualitative research and systematic
analysis of women’s preferences for care.
• Such work can be used to develop clinical decision-making tools and to promote
shared decision making about treatment between women and their providers.
• Trials should be large enough to provide direct evidence on the effects of
nonsurgical and surgical treatments on patient-centered outcomes, including
quality of life and physical functioning, and to permit analyses specific to
women of childbearing age.
• Studies of the direct and indirect costs of leiomyomas are needed to better
inform clinicians and third-party payers.
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